tiprankstipranks
Trending News
More News >
Kenvue, Inc. (KVUE)
:KVUE
US Market
Advertisement

Kenvue, Inc. (KVUE) Stock Forecast & Price Target

Compare
1,052 Followers
See the Price Targets and Ratings of:

KVUE Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
4 Buy
9 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Kenvue,
Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KVUE Stock 12 Month Forecast

Average Price Target

$21.95
▲(27.32% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Kenvue, Inc. in the last 3 months. The average price target is $21.95 with a high forecast of $26.00 and a low forecast of $17.50. The average price target represents a 27.32% change from the last price of $17.24.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","27":"$27","18.75":"$18.75","21.5":"$21.5","24.25":"$24.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$26.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$21.95</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$17.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,18.75,21.5,24.25,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.78,21.181538461538462,21.583076923076923,21.984615384615385,22.386153846153846,22.787692307692307,23.189230769230768,23.590769230769233,23.992307692307694,24.393846153846155,24.795384615384616,25.196923076923078,25.59846153846154,{"y":26,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.78,20.87,20.96,21.05,21.14,21.23,21.32,21.41,21.5,21.59,21.68,21.77,21.86,{"y":21.95,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.78,20.52769230769231,20.275384615384617,20.023076923076925,19.770769230769233,19.51846153846154,19.26615384615385,19.013846153846153,18.76153846153846,18.50923076923077,18.256923076923076,18.004615384615384,17.752307692307692,{"y":17.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.16,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.96,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.91,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.59,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.76,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.7,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.17,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.53,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.44,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.77,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.78,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$26.00Average Price Target$21.95Lowest Price Target$17.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on KVUE
Canaccord Genuity
Canaccord Genuity
$26
Buy
50.81%
Upside
Reiterated
09/23/25
Kenvue, Inc. (KVUE) Receives a Buy from Canaccord Genuity
Barclays
$20$23
Hold
33.41%
Upside
Reiterated
09/23/25
Barclays 'rough math' suggests Kenvue selloff overdone Barclays 'rough math' suggests Kenvue selloff overdone
Evercore ISI Analyst forecast on KVUE
Evercore ISI
Evercore ISI
$23$18
Hold
4.41%
Upside
Reiterated
09/23/25
Kenvue, Inc.: Hold Rating Amid FDA Concerns and Balanced RisksWe are not lawyers and have not received any legal counsel over changes in litigation risk from today’s announcement. Therefore, the analyses below adhere to the assessment of the financial impacts from headline and reputational risks, and from potential changes in consumer behavior going forward. The updated sum-of-the-parts valuation solves for $15-28 per share and we lower our price target to $18, which is the midpoint of the low and medium valuations outlined on pages 8 and 9.
TR | OpenAI - 4o Analyst forecast on KVUE
TR | OpenAI - 4o
TR | OpenAI - 4o
$19.5$17.5
Hold
1.51%
Upside
Reiterated
09/23/25
AI Generated ArticleAI Generated Article
Citi
$20
Hold
16.01%
Upside
Reiterated
09/22/25
Hold Rating for Kenvue, Inc. Amidst Market Reaction to Government Advisories on Acetaminophen
Goldman Sachs Analyst forecast on KVUE
Goldman Sachs
Goldman Sachs
$22
Hold
27.61%
Upside
Reiterated
09/08/25
Goldman Sachs Reaffirms Their Hold Rating on Kenvue, Inc. (KVUE)Goldman Sachs analyst Bonnie Herzog reiterated a Neutral rating and $22.00 price target on Kenvue Inc (NYSE: KVUE).
Deutsche Bank  Analyst forecast on KVUE
Deutsche Bank
Deutsche Bank
$21$20
Hold
16.01%
Upside
Reiterated
09/08/25
Kenvue, Inc. (KVUE) Gets a Hold from Deutsche Bank
Bank of America Securities Analyst forecast on KVUE
Bank of America Securities
Bank of America Securities
$25
Buy
45.01%
Upside
Reiterated
09/05/25
Kenvue, Inc. (KVUE) Gets a Buy from Bank of America SecuritiesBofA Securities analyst Anna Lizzul reiterated a Buy rating and $25.00 price target on Kenvue Inc (NYSE: KVUE).
J.P. Morgan
Buy
Reiterated
09/05/25
Positive Buy Rating for Kenvue, Inc. Amid Favorable Legal and Regulatory Developments
RBC Capital Analyst forecast on KVUE
RBC Capital
RBC Capital
$22
Hold
27.61%
Upside
Reiterated
09/05/25
RBC says scientific link between Tylenol and autism unproven in courtRBC says scientific link between Tylenol and autism unproven in court
UBS
$23
Hold
33.41%
Upside
Assigned
09/05/25
Kenvue, Inc. Hold Rating: Concerns Over Tylenol-Autism Link and Strategic Uncertainty
Jefferies Analyst forecast on KVUE
Jefferies
Jefferies
$26$25
Buy
45.01%
Upside
Reiterated
08/08/25
Kenvue, Inc. (KVUE) Gets a Buy from JefferiesJefferies analyst Keith Devas lowered the price target on Kenvue Inc (NYSE: KVUE) to $25.00 (from $26.00) while maintaining a Buy rating.
William Blair Analyst forecast on KVUE
William Blair
William Blair
Hold
Reiterated
08/07/25
Kenvue, Inc.: Hold Rating Amid Mixed Performance and Uncertain Outlook
Piper Sandler Analyst forecast on KVUE
Piper Sandler
Piper Sandler
$27
Buy
56.61%
Upside
Reiterated
05/05/25
Kenvue, Inc. (KVUE) Receives a Buy from Piper Sandler
Redburn Atlantic Analyst forecast on KVUE
Redburn Atlantic
Redburn Atlantic
$23.5
Hold
36.31%
Upside
Initiated
04/10/25
Kenvue initiated with a Neutral at Redburn AtlanticKenvue initiated with a Neutral at Redburn Atlantic
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on KVUE
Canaccord Genuity
Canaccord Genuity
$26
Buy
50.81%
Upside
Reiterated
09/23/25
Kenvue, Inc. (KVUE) Receives a Buy from Canaccord Genuity
Barclays
$20$23
Hold
33.41%
Upside
Reiterated
09/23/25
Barclays 'rough math' suggests Kenvue selloff overdone Barclays 'rough math' suggests Kenvue selloff overdone
Evercore ISI Analyst forecast on KVUE
Evercore ISI
Evercore ISI
$23$18
Hold
4.41%
Upside
Reiterated
09/23/25
Kenvue, Inc.: Hold Rating Amid FDA Concerns and Balanced RisksWe are not lawyers and have not received any legal counsel over changes in litigation risk from today’s announcement. Therefore, the analyses below adhere to the assessment of the financial impacts from headline and reputational risks, and from potential changes in consumer behavior going forward. The updated sum-of-the-parts valuation solves for $15-28 per share and we lower our price target to $18, which is the midpoint of the low and medium valuations outlined on pages 8 and 9.
TR | OpenAI - 4o Analyst forecast on KVUE
TR | OpenAI - 4o
TR | OpenAI - 4o
$19.5$17.5
Hold
1.51%
Upside
Reiterated
09/23/25
AI Generated ArticleAI Generated Article
Citi
$20
Hold
16.01%
Upside
Reiterated
09/22/25
Hold Rating for Kenvue, Inc. Amidst Market Reaction to Government Advisories on Acetaminophen
Goldman Sachs Analyst forecast on KVUE
Goldman Sachs
Goldman Sachs
$22
Hold
27.61%
Upside
Reiterated
09/08/25
Goldman Sachs Reaffirms Their Hold Rating on Kenvue, Inc. (KVUE)Goldman Sachs analyst Bonnie Herzog reiterated a Neutral rating and $22.00 price target on Kenvue Inc (NYSE: KVUE).
Deutsche Bank  Analyst forecast on KVUE
Deutsche Bank
Deutsche Bank
$21$20
Hold
16.01%
Upside
Reiterated
09/08/25
Kenvue, Inc. (KVUE) Gets a Hold from Deutsche Bank
Bank of America Securities Analyst forecast on KVUE
Bank of America Securities
Bank of America Securities
$25
Buy
45.01%
Upside
Reiterated
09/05/25
Kenvue, Inc. (KVUE) Gets a Buy from Bank of America SecuritiesBofA Securities analyst Anna Lizzul reiterated a Buy rating and $25.00 price target on Kenvue Inc (NYSE: KVUE).
J.P. Morgan
Buy
Reiterated
09/05/25
Positive Buy Rating for Kenvue, Inc. Amid Favorable Legal and Regulatory Developments
RBC Capital Analyst forecast on KVUE
RBC Capital
RBC Capital
$22
Hold
27.61%
Upside
Reiterated
09/05/25
RBC says scientific link between Tylenol and autism unproven in courtRBC says scientific link between Tylenol and autism unproven in court
UBS
$23
Hold
33.41%
Upside
Assigned
09/05/25
Kenvue, Inc. Hold Rating: Concerns Over Tylenol-Autism Link and Strategic Uncertainty
Jefferies Analyst forecast on KVUE
Jefferies
Jefferies
$26$25
Buy
45.01%
Upside
Reiterated
08/08/25
Kenvue, Inc. (KVUE) Gets a Buy from JefferiesJefferies analyst Keith Devas lowered the price target on Kenvue Inc (NYSE: KVUE) to $25.00 (from $26.00) while maintaining a Buy rating.
William Blair Analyst forecast on KVUE
William Blair
William Blair
Hold
Reiterated
08/07/25
Kenvue, Inc.: Hold Rating Amid Mixed Performance and Uncertain Outlook
Piper Sandler Analyst forecast on KVUE
Piper Sandler
Piper Sandler
$27
Buy
56.61%
Upside
Reiterated
05/05/25
Kenvue, Inc. (KVUE) Receives a Buy from Piper Sandler
Redburn Atlantic Analyst forecast on KVUE
Redburn Atlantic
Redburn Atlantic
$23.5
Hold
36.31%
Upside
Initiated
04/10/25
Kenvue initiated with a Neutral at Redburn AtlanticKenvue initiated with a Neutral at Redburn Atlantic
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kenvue, Inc.

1 Month
xxx
Success Rate
8/15 ratings generated profit
53%
Average Return
+2.09%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of +2.09% per trade.
3 Months
xxx
Success Rate
7/15 ratings generated profit
47%
Average Return
-0.99%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of -0.99% per trade.
1 Year
Success Rate
8/15 ratings generated profit
53%
Average Return
+1.83%
reiterated a buy rating 20 days ago
Copying Andrea Faria Teixeira's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of +1.83% per trade.
2 Years
xxx
Success Rate
4/15 ratings generated profit
27%
Average Return
-5.95%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.67% of your transactions generating a profit, with an average return of -5.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KVUE Analyst Recommendation Trends

Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
0
0
0
0
1
Buy
12
9
11
13
14
Hold
19
21
24
22
28
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
30
35
35
43
In the current month, KVUE has received 15 Buy Ratings, 28 Hold Ratings, and 0 Sell Ratings. KVUE average Analyst price target in the past 3 months is 21.95.
Each month's total comprises the sum of three months' worth of ratings.

KVUE Financial Forecast

KVUE Earnings Forecast

Next quarter’s earnings estimate for KVUE is $0.27 with a range of $0.24 to $0.29. The previous quarter’s EPS was $0.29. KVUE beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.92% of the time in the same period. In the last calendar year KVUE has Outperformed its overall industry.
Next quarter’s earnings estimate for KVUE is $0.27 with a range of $0.24 to $0.29. The previous quarter’s EPS was $0.29. KVUE beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.92% of the time in the same period. In the last calendar year KVUE has Outperformed its overall industry.

KVUE Sales Forecast

Next quarter’s sales forecast for KVUE is $3.83B with a range of $3.79B to $3.89B. The previous quarter’s sales results were $3.84B. KVUE beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 52.40% of the time in the same period. In the last calendar year KVUE has Outperformed its overall industry.
Next quarter’s sales forecast for KVUE is $3.83B with a range of $3.79B to $3.89B. The previous quarter’s sales results were $3.84B. KVUE beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 52.40% of the time in the same period. In the last calendar year KVUE has Outperformed its overall industry.

KVUE Stock Forecast FAQ

What is KVUE’s average 12-month price target, according to analysts?
Based on analyst ratings, Kenvue, Inc.’s 12-month average price target is 21.95.
    What is KVUE’s upside potential, based on the analysts’ average price target?
    Kenvue, Inc. has 27.32% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is KVUE a Buy, Sell or Hold?
          Kenvue, Inc. has a consensus rating of Moderate Buy which is based on 4 buy ratings, 9 hold ratings and 0 sell ratings.
            What is Kenvue, Inc.’s price target?
            The average price target for Kenvue, Inc. is 21.95. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $26.00 ,the lowest forecast is $17.50. The average price target represents 27.32% Increase from the current price of $17.24.
              What do analysts say about Kenvue, Inc.?
              Kenvue, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of KVUE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis